eClinical news in brief
ClinPhone, Phase Forward, etrials and DecisionView.
inVentiv Health's Clinical Solutions division has signed a new agreement with ClinPhone to help it accelerate the clinical trials of its customers using eClinical software. Under the terms of the agreement, inVentiv will complete a technology and knowledge transfer of ClinPhone's electronic data capture (EDC) software. "This agreement with ClinPhone allows us to further broaden our service offering by adding our own EDC system which will no doubt better service the increasing needs of our clients for speed and accuracy of clinical trial data," Mike Hlinak, president and CEO of inVentiv said. The news comes shortly after US-based CRO Kendle has chosen ClinPhone's EDC software as its "preferred solution" and said it will now standardise its method of capturing clinical data for its biopharmaceutical customers worldwide. In February ClinPhone was the first clinical technology organisation to receive CDISC (Clinical Data Interchange Standards Consortium) certification, which verifies that its EDC product has been validated and certified for its operational data model (ODM: a standard for data interchange) Export capabilities. In the past, its EDC technology has also been ranked as the easiest product in the industry to use, by Forrester research. Recently Parexel has decided to extend its eight-year alliance with Phase Forward, inking a new multi-year contract of an undisclosed value. The contract allows Parexel to continue to offer Phase Forward's InForm EDC software, which it described as "an integral part of its solution set." Meanwhile, last month etrials announced that during its second quarter it was awarded four new projects through its CRO Partnership Program. Two of the contracts were from new clients, one being a large global firm for a haematology trial and the other a small specialty firm specialising in the central nervous system (CNS) therapies. The two remaining projects were picked up from an existing client who also happens to have a CNS focus. "These four new projects are expected to run from as short as six months to as long as seven years, are valued at approximately $1.2m (€0.8m)," said the firm, who added that they include both EDC and eDiary software and services. In other news, DecisionView has launched version 3.5 of its StudyOptimizer solution, what it claims is the life science industry's "first business performance optimisation application for clinical trials." The new version is said to deliver recruitment planning that includes recruitment rate variables such as seasonality for developing clinical recruitment plans; advanced simulation modelling and predictive analytics that enable clinical study managers to model course corrections and alternative recruitment strategies; and rich interactive visualisations, including performance alerts and dashboards at the study, country and site level. In addition, DecisionView claims StudyOptimizer 3.5 further enhances automated data aggregation from disparate financial and clinical systems, such as EDC, in order to improve clinical team productivity. "Today's studies must reach a global patient pool and succeed in meeting their enrollment targets," said the firm. "The system automates the clinical recruitment process… resulting in shorter cycle times, reduced recruitment costs and improved clinical operational efficiencies."
